News Sentiment

IMNM sentiment intelligence

Immunome Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 58 Balanced news tone 59 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 23.35 Week of 10 Jul 2026
Weighted tone 58/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

84/100 classification confidence.

Company focus 50

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-1.1% over one week, +27.0% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

Why Immunome (IMNM) Is Down 8.2% After FDA Accepts Varegacestat NDA With Strong Phase 3 Data

Market Reaction

Balanced read

69/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 84/100 classification
One-week reaction -1.1% Price digesting
Trend fit Trend inactive 27.0% over four weeks
Fair value 65.9% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 18
Neutral 38
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 50
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 13
Market source 9
MT Newswires 6
simplywall.st 4
Moomoo 3
Investing.com 3
Business Wire 3
Investing.com Nigeria 2

Event Lens

What the news is about

Classified themes
Market update 39
Earnings 10
Analyst action 7
Guidance 1
Regulatory and legal 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-59 of 59
Stock Titan Direct company coverage

[144] Immunome Inc. SEC Filing

This article reports on an SEC Form 144 filing by Immunome Inc. (IMNM), indicating a proposed sale of securities. The filing details the filer information, issuer information, securities to be sold (common stock acquired via stock option exercise), and the broker involved. The do

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 20:11
Source
Stock Titan
Investing.com Canada Direct company coverage

Form 144 Immunome For: 6 July By Investing.com

The article is a brief financial update from Investing.com, stating "Form 144 Immunome For: 6 July". It includes the stock symbol IMNM and notes a 1.23% increase. The content appears to be a placeholder or a very short news item, possibly indicating an SEC filing.

Tone
Neutral 50/100
Event
Market update
Published
06 Jul 2026 22:09
Source
Investing.com Canada
Stock Titan Direct company coverage

IMNM (Nasdaq) affiliate filings report multiple share sales, including 100,000-share entries

Immunome Inc. (IMNM) affiliates have filed Form 144s reporting multiple share sales. These filings indicate an intended sale of 100,000 shares from a private placement dating back to October 2023, and recent sales including two 100,000-share entries and one 1,050-share entry by e

Tone
Neutral 50/100
Event
Market update
Published
06 Jul 2026 21:09
Source
Stock Titan